Sunday, January 16, 2011
HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy
PurposePrimary chemotherapy brings the opportunity for an early and accurate assessment of response and offers an ideal model to search for new predictors of response. HER-2/neu is one of the most studied genes for this purpose.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment